Skip to main content
Veterinary Medicines

Rabisin

Authorised
  • Rabies virus, strain G52, Inactivated

Dettalji tal-prodott

Sustanza attiva / Qawwa:
  • Disponibbli biss fi English
    0.00
    milligram(s)
    /
    1.00
    Dose
Forma farmaċewtika:
  • Suspensjoni għall-injezzjoni
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
    • Sheep
      • Meat and offal
        0
        day
    • Horse
    • Other Mammals
  • Subcutaneous use
    • Cattle
    • Dog
    • Cat
    • Other Mammals
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
  • QI07AA02
Status tal-awtorizzazzjoni:
  • Valid
Authorised in:
Din l-informazzjoni mhijiex disponibbli għal dan il-prodott.
Deskrizzjoni tal-pakkett:

Tagħrif addizzjonali

Entitlement type:
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
  • Boehringer Ingelheim Animal Health France
Awtorità responsabbli:
  • Health Products Regulatory Authority
Numru tal-awtorizzazzjoni:
  • VPA10454/074/001
Data tal-bidla fl-istatus tal-awtorizzazzjoni:

Dokumenti

Sommarju tal-karatteristiċi tal-prodott

Dan id-dokument ma jeżistix f'dan il-lingwa (Malti). Tista 'ssibha f'lingwa oħra hawn taħt.
English (PDF)
Ippubblikat fuq: 8/03/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."